BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

AstraZeneca Acquires Gracell, Expanding Cell Therapy Goals in Oncology and Autoimmune Diseases.

AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage biopharmaceuti...

December 28, 2023 | News

Bristol Myers Squibb Acquires Karuna Therapeutics for $14 Billion

KarXT Is a Potential First-in-Class Treatment for Schizophrenia and as an Adjunctive Therapy, and First-in-Disease Treatment for Alzheimer’s Di...

December 26, 2023 | News

LTS Secures $4.3M Grant for Contraceptive Microneedle Array Patch Development

Poor access to contraceptives presents a significant burden for women living in LMICs. According to a 2022 study, one in 14 women worldwide who want to use...

December 20, 2023 | News

Biorithm Raises $3.5M in Series A to Advance Global Maternal Care

Biorithm, a global women's health medtech, has closed $3.5 million in Series A funding, co-led by Adaptive Capital Partners and SEEDS Capital. Wi...

December 19, 2023 | News

Fosun Pharma's Antimalarial Drug Trial Gets 500 Million Yen Boost from GHIT Fund for Global Accessibility Initiative

The Japan-based Global Health Innovative Technology Fund (GHIT Fund) announced that it will invest approximately US$3.3 million (approximate...

December 15, 2023 | News

Nona Biosciences and Pfizer Strike Global Deal for MSLN-Targeted ADC HBM9033

Under the terms of the agreement, Nona Biosciences will receive a total of up to $53 million in upfront and near-term payments, with the potentia...

December 15, 2023 | News

Gilead Sciences Funds HIV Projects in Asia Pacific with $1.5M

–2023 Gilead Asia Pacific Rainbow Grant Funding Will Support 40 Projects In 2024-2025 To Reduce HIV Stigma And Improve Equity Across Asia Pacific &nd...

November 29, 2023 | News

Viva Biotech Secures Approximately US$ 210 Million Funding

Before, the publicly listed company at the group level had already secured approximately US$ 60 million in convertible bond financing, which will...

November 21, 2023 | News

Micron Biomedical Secures $23.6M to Advance Needle-Free Vaccine Production for Measles Eradication

Micron has received this grant from the Bill & Melinda Gates Foundation to fund mass production of needle-free vaccines utilizing Micron technology t...

November 20, 2023 | News

South Korean Firm Lunit Raises $150 Million in Capital Boost

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the successful completion ...

November 16, 2023 | News

Ajinomoto Group Makes Strategic Move into Gene Therapy with $750 Million Acquisition of Forge Biologics, Bolstering Healthcare Portfolio for Exponential Growth

In the Medium-Term ASV Initiatives 2030 Roadmap, announced in February this year, Ajinomoto Co. identified four strategic growth areas including Healthcare...

November 15, 2023 | News